Apimeds Pharmaceuticals US, Inc. (APUS) stock

APUSNYSEPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30

$2.27−0.09 (-3.81%)

Close on Nov 12, 2026Market cap $3.43MP/E –Yield –

Apimeds Pharmaceuticals US statistics

59 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: –
Last ex-dividend date: No dividends
Fundamentals through: Jun 30, 2026
Share price as of: Nov 12, 2026

Valuation ratiosIndustry

Market Cap: $3.43M; $280.48M
Enterprise Value: $3.15M; $148.62M
PB Ratio: 0.03; 2.05
P/TBV Ratio: 0.03; 2.29

Share statisticsIndustry

Shares Outstanding: 2M; 58M
Shares Change (YoY): 69.7%; 10.9%
Shares Change (QoQ): 20.0%; 0.51%
Shares Held by Institutions: 2.82%; 56.4%

Short sellingIndustry

Short Interest: 31,812; –
Short Interest Change: -56.4%; -0.76%
Short % of Shares Outstanding: 2.11%; 6.30%
Days to Cover: 1.00; 5.13

Stock price statisticsIndustry

52-Week High: $59.70; –
52-Week Low: $1.51; –
20-Day Moving Average: $2.99; –
50-Day Moving Average: $3.44; –
200-Day Moving Average: $10.20; –
Average True Range (14): $0.56; –
Price Change (1 Week): -16.8%; 1.51%
Price Change (1 Month): -50.4%; -2.35%
Price Change (3 Months): -50.1%; -21.1%
Price Change (6 Months): -83.4%; -22.6%
Price Change (YTD): -86.2%; -22.6%
Price Change (1 Year): -91.5%; -20.7%
Average Volume (10 Days): 32,416; –
Average Volume (20 Days): 51,888; –
Average Volume (90 Days): 3M; –
Relative Volume: 0.01; 0.79
Relative Strength Index (14): 35.1; 44.7
Volatility (1 Year): 211.2%; 80.4%

Returns on capitalIndustry

Return on Equity (ROE): -100.1%; -51.2%
Return on Assets (ROA): -84.2%; -40.6%
Return on Invested Capital (ROIC): -40.3%; -32.9%
Return on Capital Employed (ROCE): -25.7%; -38.0%

Financial positionIndustry

Current Ratio: 0.51; 3.30
Quick Ratio: 0.01; 2.42
Interest Coverage: -6.35; -6.35

EfficiencyIndustry

Profits Per Employee: -$6.46M; -$683.67K
Employee Count: 9; 75

Income statement (TTM)Industry

Operating Income: -$27.35M; -$20.99M
Net Income: -$58.17M; -$21.61M
EBITDA: -$27.35M; -$16.85M
EPS (Diluted): -$36.69; -$0.75

Balance sheetIndustry

Cash & Short-Term Investments: $278.37K; $67.63M
Net Cash (Debt): $278.37K; $17.46M
Net Cash Per Share: $0.18; $0.72
Equity (Book Value): $106.45M; $53.27M
Book Value Per Share: $70.54; $1.50
Tangible Book Value: $106.45M; $26.82M
Working Capital: -$10.39M; $79.47M

Cash flow (TTM)Industry

Operating Cash Flow: -$13.28M; -$12.27M
Capital Expenditures: -$53.36K; -$944.00K
Free Cash Flow: -$13.33M; -$18.20M
FCF Per Share: -$8.83; -$0.42

Dividends and yieldsIndustry

Earnings Yield: -1698.0%; -20.8%
FCF Yield: -389.2%; -9.58%

Taxes and interestIndustry

Interest Expense: $4.31M; $2.93M

Scores and fair valueIndustry

Altman Z-Score: -1.43; 0.30
Piotroski F-Score: 4; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

Period	APUS	S&P 500	Difference
1 month	-56.3%	-2.7%	−53.6 pts
3 months	-51.3%	-1.7%	−49.5 pts
Year to date	-86.2%	+11.9%	−98.1 pts
1 year	-91.5%	+12.0%	−103.5 pts

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M APUS shares were sold short on Oct 30, 2026, down 56.4% from the previous report. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 45.5% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	31,812	-56.4%	66,825	1.0
Oct 15, 2026	73,009	-8.2%	9,714,268	1.0
Sep 30, 2026	79,539	+668.8%	11,747,902	1.0
Sep 15, 2026	10,346	-48.1%	39,482	1.0
Aug 31, 2026	19,919	+33.3%	249,132	1.0
Aug 14, 2026	14,942	-44.3%	47,353	1.0
Jul 31, 2026	26,814	-84.7%	59,614	1.0
Jul 15, 2026	175,782	-24.0%	201,885	1.0
Jun 30, 2026	231,171	+57.0%	167,885	1.4
Jun 15, 2026	147,268	-11.6%	31,873	4.6
May 29, 2026	166,663	-11.4%	32,818	5.1
May 15, 2026	188,109	+102.3%	656,206	1.0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?